GlaxoSmithKline

XenoPort's CEO Discusses Q4 2012 Results - Earnings Call Transcript

XenoPort Reports Fourth Quarter and Year-End 2012 Financial Results

5 Dividend Stocks Favored By Warren Buffett

Buyout Giants Get Taste For Ribena

Drug, Chemical & Associated Technologies Association to host conference

Substance Abuse Therapeutics Market to 2018 - Effective Drug Therapies in the Treatment of Alcohol and Opioid Dependence Offer Significant Market Opportunities

Progenitor Labs secures £4 million financing to progress potentially game-changing regenerative medicine platform

CEOs applaud protection of overseas aid

GSK CEO's performance pay slides

GlaxoSmithKline Files for Diabetes Drug's European Approval